Nabriva Therapeutics
NBRV
$1.42
Share price
0.00%
Change (1 day)
-71.20%
Change (1 year)
Categories
EPS for Nabriva Therapeutics (NBRV)
EPS in 2023 (TTM): -$19.20
According to Nabriva Therapeutics 's latest financial reports the company's current EPS (TTM) is -$19.20. In 2022 the company made an earnings per share (EPS) of -$21.51 an increase over its 2021 EPS that were of -$31.77.
EPS history for Nabriva Therapeutics from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$19.20 | -10.74% |
| 2022 | -$21.51 | -32.29% |
| 2021 | -$31.77 | -78.24% |
| 2020 | -$146.00 | -47.86% |
| 2019 | -$280.00 | -46.92% |
| 2018 | -$527.50 | -15.26% |
| 2017 | -$622.50 | -2.81% |
| 2016 | -$640.50 | 122.82% |
| 2015 | -$287.45 | 117.01% |
| 2014 | -$132.46 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -88.65% | 🇺🇸 USA |